BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35505028)

  • 1. In Vitro Assessment of Binding Affinity, Selectivity, Uptake, Intracellular Degradation, and Toxicity of Nanobody-Photosensitizer Conjugates.
    Beltrán Hernández I; De Groof TWM; Heukers R; Oliveira S
    Methods Mol Biol; 2022; 2451():505-520. PubMed ID: 35505028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanobody-targeted photodynamic therapy induces significant tumor regression of trastuzumab-resistant HER2-positive breast cancer, after a single treatment session.
    Deken MM; Kijanka MM; Beltrán Hernández I; Slooter MD; de Bruijn HS; van Diest PJ; van Bergen En Henegouwen PMP; Lowik CWGM; Robinson DJ; Vahrmeijer AL; Oliveira S
    J Control Release; 2020 Jul; 323():269-281. PubMed ID: 32330574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanobody-Targeted Photodynamic Therapy: Nanobody Production and Purification.
    Mashayekhi V; Schooten E; van Bergen En Henegouwen PMP; Kijanka MM; Oliveira S
    Methods Mol Biol; 2022; 2451():481-493. PubMed ID: 35505026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanobody-Targeted Photodynamic Therapy Selectively Kills Viral GPCR-Expressing Glioblastoma Cells.
    De Groof TWM; Mashayekhi V; Fan TS; Bergkamp ND; Sastre Toraño J; van Senten JR; Heukers R; Smit MJ; Oliveira S
    Mol Pharm; 2019 Jul; 16(7):3145-3156. PubMed ID: 31244224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGFR targeted nanobody-photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer.
    van Driel PBAA; Boonstra MC; Slooter MD; Heukers R; Stammes MA; Snoeks TJA; de Bruijn HS; van Diest PJ; Vahrmeijer AL; van Bergen En Henegouwen PMP; van de Velde CJH; Löwik CWGM; Robinson DJ; Oliveira S
    J Control Release; 2016 May; 229():93-105. PubMed ID: 26988602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orthotopic Breast Cancer Model to Investigate the Therapeutic Efficacy of Nanobody-Targeted Photodynamic Therapy.
    Deken MM; Bhairosingh SS; Vahrmeijer AL; Oliveira S
    Methods Mol Biol; 2022; 2451():547-556. PubMed ID: 35505031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the Therapeutic Potential of Nanobody-Targeted Photodynamic Therapy in an Orthotopic Head and Neck Cancer Model.
    van Driel PBAA; Keereweer S; Lowik CWGM; Oliveira S
    Methods Mol Biol; 2022; 2451():521-531. PubMed ID: 35505029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of subcellular localization on the efficiency of EGFR-targeted VHH photosensitizer conjugates.
    van Lith SAM; van den Brand D; Wallbrecher R; Wübbeke L; van Duijnhoven SMJ; Mäkinen PI; Hoogstad-van Evert JS; Massuger L; Ylä-Herttuala S; Brock R; Leenders WPJ
    Eur J Pharm Biopharm; 2018 Mar; 124():63-72. PubMed ID: 29274374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the In Vivo Response to Nanobody-Targeted PDT Through Intravital Microscopy.
    de Bruijn HS; Seynhaeve ALB; Ten Hagen TLM; Oliveira S; Robinson DJ
    Methods Mol Biol; 2022; 2451():533-545. PubMed ID: 35505030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanobody-photosensitizer conjugates for targeted photodynamic therapy.
    Heukers R; van Bergen en Henegouwen PM; Oliveira S
    Nanomedicine; 2014 Oct; 10(7):1441-51. PubMed ID: 24394212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFR-Targeted Nanobody Functionalized Polymeric Micelles Loaded with mTHPC for Selective Photodynamic Therapy.
    Liu Y; Scrivano L; Peterson JD; Fens MHAM; Hernández IB; Mesquita B; Toraño JS; Hennink WE; van Nostrum CF; Oliveira S
    Mol Pharm; 2020 Apr; 17(4):1276-1292. PubMed ID: 32142290
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging.
    de Bruijn HS; Mashayekhi V; Schreurs TJL; van Driel PBAA; Strijkers GJ; van Diest PJ; Lowik CWGM; Seynhaeve ALB; Hagen TLMT; Prompers JJ; Henegouwen PMPVBE; Robinson DJ; Oliveira S
    Theranostics; 2020; 10(5):2436-2452. PubMed ID: 32089747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual Targeting of Endothelial and Cancer Cells Potentiates In Vitro Nanobody-Targeted Photodynamic Therapy.
    Mashayekhi V; Xenaki KT; van Bergen En Henegouwen PMP; Oliveira S
    Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32977602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting of a hydrophilic photosensitizer by use of internalizing monoclonal antibodies: A new possibility for use in photodynamic therapy.
    Vrouenraets MB; Visser GW; Loup C; Meunier B; Stigter M; Oppelaar H; Stewart FA; Snow GB; van Dongen GA
    Int J Cancer; 2000 Oct; 88(1):108-14. PubMed ID: 10962447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjugation of IRDye Photosensitizers or Fluorophores to Nanobodies.
    Mashayekhi V; Oliveira S
    Methods Mol Biol; 2022; 2451():495-503. PubMed ID: 35505027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penetration of Nanobody-Dextran Polymer Conjugates through Tumor Spheroids.
    Bitsch P; Baum ES; Beltrán Hernández I; Bitsch S; Harwood J; Oliveira S; Kolmar H
    Pharmaceutics; 2023 Sep; 15(10):. PubMed ID: 37896133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The synthesis of 64Cu-chelated porphyrin photosensitizers and their tumor-targeting peptide conjugates for the evaluation of target cell uptake and PET image-based pharmacokinetics of targeted photodynamic therapy agents.
    Mukai H; Wada Y; Watanabe Y
    Ann Nucl Med; 2013 Aug; 27(7):625-39. PubMed ID: 23605059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular photodynamic therapy with photosensitizer-nanoparticle conjugates: cancer therapy using a 'Trojan horse'.
    Wieder ME; Hone DC; Cook MJ; Handsley MM; Gavrilovic J; Russell DA
    Photochem Photobiol Sci; 2006 Aug; 5(8):727-34. PubMed ID: 16886087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pheophorbide-a conjugates with cancer-targeting moieties for targeted photodynamic cancer therapy.
    You H; Yoon HE; Jeong PH; Ko H; Yoon JH; Kim YC
    Bioorg Med Chem; 2015 Apr; 23(7):1453-62. PubMed ID: 25753328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotechology-based strategies to enhance the efficacy of photodynamic therapy for cancers.
    Li WT
    Curr Drug Metab; 2009 Oct; 10(8):851-60. PubMed ID: 20214580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.